Galantamine is an acetylcholinesterase inhibitor used to manage Alzheimer disease by elevating acetylcholine levels in the brain, thereby improving cognitive function and memory. This activity reviews galantamine's indications, mechanism of action, contraindications, and adverse events. Additionally, essential considerations will be discussed, including dosing guidelines, pharmacokinetics, pharmacodynamics, potential drug-drug interactions, and necessary monitoring strategies. Special attention is given to warnings associated with galantamine and identifying specific patient populations where galantamine should be prescribed cautiously. This session provides healthcare professionals with the knowledge required to customize treatment plans effectively, enhancing therapeutic outcomes for patients with dementia, particularly those with Alzheimer disease. Emphasis is placed on the integral role of the interprofessional healthcare team in managing and supervising galantamine therapy to optimize patient care.
Copyright © 2024, StatPearls Publishing LLC.